Cargando…
COVID-19 prophylaxis with immunoglobulin Y (IgY) for the world population: The critical role that governments and non-governmental organizations can play
Autores principales: | Frumkin, Lyn R, Lucas, Michaela, Wallach, Michael, Scribner, Curtis L, St John, Tom, Mochly-Rosen, Daria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society of Global Health
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719602/ https://www.ncbi.nlm.nih.gov/pubmed/36462205 http://dx.doi.org/10.7189/jogh.12.03080 |
Ejemplares similares
-
Egg-Derived Anti-SARS-CoV-2 Immunoglobulin Y (IgY) With Broad Variant Activity as Intranasal Prophylaxis Against COVID-19
por: Frumkin, Lyn R., et al.
Publicado: (2022) -
Immunoglobulin Y for Potential Diagnostic and Therapeutic Applications in Infectious Diseases
por: Lee, Lucia, et al.
Publicado: (2021) -
Affordable IgY-based antiviral prophylaxis for resource-limited settings to address epidemic and pandemic risks
por: Chen, Carrie J, et al.
Publicado: (2022) -
Feasibility of Polyclonal Avian Immunoglobulins (IgY) as Prophylaxis against Human Norovirus Infection
por: Artman, Chad, et al.
Publicado: (2022) -
Opinion: The use of chicken IgY in the control of pandemics
por: Wallach, Michael G.
Publicado: (2022)